SCHEMBL23861639

SCHEMBL23861639

CC(c1ccc2ccccc2c1)(c1c(O)ccc2cc(O)ccc12)c1c(O)ccc2cc(O)ccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.49
▸ MPL P40238 1/20 0.40
▸ TLR8 Q9NR97 1/20 0.40
▸ ESR2 Q92731 6/20 0.40
▸ ESR1 P03372 5/20 0.40
▸ HSD17B2 P37059 3/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ CYP2D6 P10635 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ HSD17B1 P14061 2/20 0.38
▸ CYP2B6 P20813 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ NQO2 P16083 1/20 0.38
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ ATM Q13315 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861487 0.90 CYP1A2 (0.46) CYP1A2MPLESR2ESR1HSD17B2
SCHEMBL23861638 0.88 POLB (0.44) CYP1A2ESR2ESR1HSD17B2CYP2C9
SCHEMBL23861565 0.88 ESR1 (0.40) CYP1A2MPLTLR8ESR2ESR1
SCHEMBL23861442 0.87 ESR2 (0.49) CYP1A2MPLTLR8ESR2ESR1
SCHEMBL23082053 0.84 ESR1 (0.54) CYP1A2MPLTLR8ESR2ESR1
SCHEMBL23861415 0.84 ESR1 (0.47) CYP1A2TLR8ESR2ESR1HSD17B2
SCHEMBL19806908 0.78 ESR1 (0.47) CYP1A2TLR8ESR2ESR1HSD17B2
SCHEMBL23861563 0.78 PTPN22 (0.48) CYP1A2ESR2ESR1HSD17B2CYP2C9
SCHEMBL23861635 0.77 ESR1 (0.39) CYP1A2MPLTLR8ESR2ESR1
SCHEMBL23861567 0.77 ESR1 (0.41) MPLESR2ESR1HSD17B2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 CYP1A2 2085/4885MPL 4078/4885TLR8 4189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback